Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Leukemia

  Free Subscription


Articles published in Oncol Rep

Retrieve available abstracts of 42 articles:
HTML format
Text format



Single Articles


    June 2017
  1. LIU Y, Shin DY, Oh S, Kim S, et al
    KML001 and doxercalciferol induce synergistic antileukemic effect in acute lymphoid leukemia cells.
    Oncol Rep. 2017 Jun 1. doi: 10.3892/or.2017.5688.
    PubMed     Text format     Abstract available


    May 2017
  2. ZHOU HR, Fu HY, Wu DS, Zhang YY, et al
    Relationship between epigenetic changes in Wnt antagonists and acute leukemia.
    Oncol Rep. 2017;37:2663-2671.
    PubMed     Text format     Abstract available


    March 2017
  3. CHEN JR, Jia XH, Wang H, Yi YJ, et al
    With no interaction, knockdown of Apollon and MDR1 reverse the multidrug resistance of human chronic myelogenous leukemia K562/ADM cells.
    Oncol Rep. 2017 Mar 29. doi: 10.3892/or.2017.5535.
    PubMed     Text format     Abstract available


  4. TAO YF, Li ZH, Du WW, Xu LX, et al
    Inhibiting PLK1 induces autophagy of acute myeloid leukemia cells via mammalian target of rapamycin pathway dephosphorylation.
    Oncol Rep. 2017;37:1419-1429.
    PubMed     Text format     Abstract available


  5. LYU X, Li J, Yun X, Huang R, et al
    miR-181a-5p, an inducer of Wnt-signaling, facilitates cell proliferation in acute lymphoblastic leukemia.
    Oncol Rep. 2017;37:1469-1476.
    PubMed     Text format     Abstract available


    February 2017
  6. LI Y, Zhao L, Li N, Miao Y, et al
    miR-9 regulates the multidrug resistance of chronic myelogenous leukemia by targeting ABCB1.
    Oncol Rep. 2017 Feb 17. doi: 10.3892/or.2017.5464.
    PubMed     Text format     Abstract available


    January 2017
  7. XU T, Yang XQ, Jiang KL, Wang H, et al
    Expression of the promyelocytic leukemia protein without the nuclear localization signal as a novel diagnostic marker for acute promyelocytic leukemia.
    Oncol Rep. 2017 Jan 9. doi: 10.3892/or.2017.5357.
    PubMed     Text format     Abstract available


    December 2016
  8. HUANG X, Qi L, Lu W, Yang G, et al
    miRNA-301a induces apoptosis of chronic myelogenous leukemia cells by directly targeting TIMP2/ERK1/2 and AKT pathways.
    Oncol Rep. 2016 Dec 22. doi: 10.3892/or.2016.5330.
    PubMed     Text format     Abstract available


  9. ZHOU W, Wang S, Ying Y, Zhou R, et al
    miR-196b/miR-1290 participate in the antitumor effect of resveratrol via regulation of IGFBP3 expression in acute lymphoblastic leukemia.
    Oncol Rep. 2016 Dec 15. doi: 10.3892/or.2016.5321.
    PubMed     Text format     Abstract available


    November 2016
  10. BRUNING A, Juckstock J, Kost B, Tsikouras P, et al
    Induction of DNA damage and apoptosis in human leukemia cells by efavirenz.
    Oncol Rep. 2016 Nov 15. doi: 10.3892/or.2016.5243.
    PubMed     Text format     Abstract available


  11. SMAHELOVA J, Kastankova I, Polakova KM, Klamova H, et al
    Expression of genes encoding centrosomal proteins and the humoral response against these proteins in chronic myeloid leukemia.
    Oncol Rep. 2016 Nov 7. doi: 10.3892/or.2016.5226.
    PubMed     Text format     Abstract available


    October 2016
  12. CHEN Y, Zhou Q, Zhang L, Wang R, et al
    Idelalisib induces G1 arrest and apoptosis in chronic myeloid leukemia K562 cells.
    Oncol Rep. 2016 Oct 17. doi: 10.3892/or.2016.5176.
    PubMed     Text format     Abstract available


  13. PARK EY, Kim JI, Leem DG, Shin JS, et al
    Resveratrol analogue (E)-8-acetoxy-2-[2-(3,4-diacetoxyphenyl)ethenyl]-quinazoline induces apoptosis via Fas-mediated pathway in HL-60 human leukemia cells.
    Oncol Rep. 2016 Oct 13. doi: 10.3892/or.2016.5168.
    PubMed     Text format     Abstract available


  14. ZHANG YY, Huang SH, Zhou HR, Chen CJ, et al
    Role of HOTAIR in the diagnosis and prognosis of acute leukemia.
    Oncol Rep. 2016 Oct 4. doi: 10.3892/or.2016.5147.
    PubMed     Text format     Abstract available


  15. PAN GZ, Zhai FX, Lu Y, Fang ZG, et al
    RUNX3 plays an important role in As2O3induced apoptosis and allows cells to overcome MSCmediated drug resistance.
    Oncol Rep. 2016;36:1927-38.
    PubMed     Text format     Abstract available


    September 2016
  16. SHI L, Weng XQ, Sheng Y, Wu J, et al
    Staurosporine enhances ATRA-induced granulocytic differentiation in human leukemia U937 cells via the MEK/ERK signaling pathway.
    Oncol Rep. 2016 Sep 23. doi: 10.3892/or.2016.5123.
    PubMed     Text format     Abstract available


  17. PANAGOPOULOS I, Torkildsen S, Gorunova L, Ulvmoen A, et al
    RUNX1 truncation resulting from a cryptic and novel t(6;21)(q25;q22) chromosome translocation in acute myeloid leukemia: A case report.
    Oncol Rep. 2016 Sep 22. doi: 10.3892/or.2016.5119.
    PubMed     Text format     Abstract available


  18. QIAN L, Zhang W, Lei B, He A, et al
    MicroRNA-101 regulates T-cell acute lymphoblastic leukemia progression and chemotherapeutic sensitivity by targeting Notch1.
    Oncol Rep. 2016 Sep 21. doi: 10.3892/or.2016.5117.
    PubMed     Text format     Abstract available


  19. HAGIHARA M, Iriyama N, Yoshida C, Wakita H, et al
    Association of pleural effusion with an early molecular response in patients with newly diagnosed chronic-phase chronic myeloid leukemia receiving dasatinib: Results of a D-First study.
    Oncol Rep. 2016 Sep 20. doi: 10.3892/or.2016.5110.
    PubMed     Text format     Abstract available


  20. TOMAN O, Kabickova T, Vit O, Fiser R, et al
    Proteomic analysis of imatinib-resistant CML-T1 cells reveals calcium homeostasis as a potential therapeutic target.
    Oncol Rep. 2016;36:1258-68.
    PubMed     Text format     Abstract available


    July 2016
  21. LIN CF, Yang JS, Lin C, Tsai FJ, et al
    CCY-1a-E2 induces G2/M phase arrest and apoptotic cell death in HL-60 leukemia cells through cyclin-dependent kinase 1 signaling and the mitochondria-dependent caspase pathway.
    Oncol Rep. 2016 Jul 25. doi: 10.3892/or.2016.4970.
    PubMed     Text format     Abstract available


  22. YU G, Yin C, Jiang L, Zheng Z, et al
    Amyloid precursor protein cooperates with c-KIT mutation/overexpression to regulate cell apoptosis in AML1-ETO-positive leukemia via the PI3K/AKT signaling pathway.
    Oncol Rep. 2016 Jul 21. doi: 10.3892/or.2016.4963.
    PubMed     Text format     Abstract available


  23. ORGANISTA-NAVA J, Gomez-Gomez Y, Illades-Aguiar B, Leyva-Vazquez MA, et al
    Regulation of the miRNA expression by TEL/AML1, BCR/ABL, MLL/AF4 and TCF3/PBX1 oncoproteins in acute lymphoblastic leukemia (Review).
    Oncol Rep. 2016 Jul 19. doi: 10.3892/or.2016.4948.
    PubMed     Text format     Abstract available


  24. FU C, Gong Y, Shi X, Sun Z, et al
    Plumbagin reduces chronic lymphocytic leukemia cell survival by downregulation of Bcl-2 but upregulation of the Bax protein level.
    Oncol Rep. 2016 Jul 19. doi: 10.3892/or.2016.4950.
    PubMed     Text format     Abstract available


  25. ZENG Y, Weng G, Fan J, Li Z, et al
    Curcumin reduces the expression of survivin, leading to enhancement of arsenic trioxide-induced apoptosis in myelodysplastic syndrome and leukemia stem-like cells.
    Oncol Rep. 2016 Jul 15. doi: 10.3892/or.2016.4944.
    PubMed     Text format     Abstract available


  26. HAN MH, Lee WS, Nagappan A, Kim HJ, et al
    Polyphenols from Korean prostrate spurge Euphorbia supina induce apoptosis through the Fas-associated extrinsic pathway and activation of ERK in human leukemic U937 cells.
    Oncol Rep. 2016;36:99-107.
    PubMed     Text format     Abstract available


  27. CHEN Y, Liu ZH, Xia J, Li XP, et al
    20(S)-ginsenoside Rh2 inhibits the proliferation and induces the apoptosis of KG-1a cells through the Wnt/beta-catenin signaling pathway.
    Oncol Rep. 2016;36:137-46.
    PubMed     Text format     Abstract available


    June 2016
  28. YU Y, Duan S, He J, Liang W, et al
    Highly sensitive detection of leukemia cells based on aptamer and quantum dots.
    Oncol Rep. 2016 Jun 10. doi: 10.3892/or.2016.4866.
    PubMed     Text format     Abstract available


  29. MA D, Jing X, Shen B, Liu X, et al
    Leukemia inhibitory factor receptor negatively regulates the metastasis of pancreatic cancer cells in vitro and in vivo.
    Oncol Rep. 2016 Jun 9. doi: 10.3892/or.2016.4865.
    PubMed     Text format     Abstract available


    April 2016
  30. ZHANG X, Wu C, Xiong W, Chen C, et al
    Knockdown of p54nrb inhibits migration, invasion and TNF-alpha release of human acute monocytic leukemia THP1 cells.
    Oncol Rep. 2016 Apr 20. doi: 10.3892/or.2016.4756.
    PubMed     Text format     Abstract available


  31. WANG H, Jia XH, Chen JR, Wang JY, et al
    Osthole shows the potential to overcome P-glycoproteinmediated multidrug resistance in human myelogenous leukemia K562/ADM cells by inhibiting the PI3K/Akt signaling pathway.
    Oncol Rep. 2016 Apr 4. doi: 10.3892/or.2016.4730.
    PubMed     Text format     Abstract available


  32. NAKAJIMA H, Murakami Y, Morii E, Akao T, et al
    Induction of eEF2-specific antitumor CTL responses in vivo by vaccination with eEF2-derived 9mer-peptides.
    Oncol Rep. 2016;35:1959-66.
    PubMed     Text format     Abstract available


    March 2016
  33. QIAN S, Sun L, Li J, Wu J, et al
    MAP30 inhibits autophagy through enhancing acetyltransferase p300 and induces apoptosis in acute myeloid leukemia cells.
    Oncol Rep. 2016 Mar 24. doi: 10.3892/or.2016.4705.
    PubMed     Text format     Abstract available


  34. CHE Y, Ren X, Xu L, Ding X, et al
    Critical involvement of the alpha(1,2)-fucosyltransferase in multidrug resistance of human chronic myeloid leukemia.
    Oncol Rep. 2016 Mar 11. doi: 10.3892/or.2016.4673.
    PubMed     Text format     Abstract available


  35. PEREZ-FIGUEROA E, Sanchez-Cuaxospa M, Martinez-Soto KA, Sanchez-Zauco N, et al
    Strong inflammatory response and Th1-polarization profile in children with acute lymphoblastic leukemia without apparent infection.
    Oncol Rep. 2016 Mar 7. doi: 10.3892/or.2016.4657.
    PubMed     Text format     Abstract available


    February 2016
  36. MONZEN S, Chiba M, Hosokawa Y
    Genetic network profiles associated with established resistance to ionizing radiation in acute promyelocytic leukemia cells and their extracellular vesicles.
    Oncol Rep. 2016;35:749-756.
    PubMed     Text format     Abstract available


  37. DI STEFANO C, Mirone G, Perna S, Marfe G, et al
    The roles of microRNAs in the pathogenesis and drug resistance of chronic myelogenous leukemia (Review).
    Oncol Rep. 2016;35:614-624.
    PubMed     Text format     Abstract available


    January 2016
  38. YUAN B, Yoshino Y, Fukushima H, Markova S, et al
    Multidrug resistance-associated protein 4 is a determinant of arsenite resistance.
    Oncol Rep. 2016;35:147-54.
    PubMed     Text format     Abstract available


    December 2015
  39. FU C, Gong Y, Shi X, Shi H, et al
    Expression and regulation of COP1 in chronic lymphocytic leukemia cells for promotion of cell proliferation and tumorigenicity.
    Oncol Rep. 2015 Dec 28. doi: 10.3892/or.2015.4526.
    PubMed     Text format     Abstract available


    November 2015
  40. CAO L, Xiao PF, Tao YF, Hu SY, et al
    Microarray profiling of bone marrow long non-coding RNA expression in Chinese pediatric acute myeloid leukemia patients.
    Oncol Rep. 2015 Nov 12. doi: 10.3892/or.2015.4415.
    PubMed     Text format     Abstract available


    July 2015
  41. VAHEDI S, Chueh FY, Dutta S, Chandran B, et al
    Nuclear lymphocyte-specific protein tyrosine kinase and its interaction with CR6-interacting factor 1 promote the survival of human leukemic T cells.
    Oncol Rep. 2015;34:43-50.
    PubMed     Text format     Abstract available


    May 2015
  42. SHIBAYAMA Y, Kondo T, Ohya H, Fujisawa S, et al
    Upregulation of microRNA-126-5p is associated with drug resistance to cytarabine and poor prognosis in AML patients.
    Oncol Rep. 2015;33:2176-82.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: